Second of Three Videos: Anti-Bribery and Foreign Corrupt Practices Act Compliance for U.S. Companies Doing Business in India
22 January 2019
We are pleased to announce the release of the second video in our India anti-bribery compliance video series. As noted previously, Foley partner David W. Simon and Sherbir Panag, of Panag & Babu in New Delhi, India have produced these videos to educate lawyers, compliance professionals, and business managers on the basics of anti-bribery compliance in India. This video, “Anti-Bribery and Foreign Corrupt Practices Act Compliance for U.S. Companies Doing Business in India,” takes a more in-depth look at common anti-bribery risks in India and provides practical tips for managing those risks. To view it, please click on this link: Typical Compliance Risks in India.
If you missed the first video in our series, “Ten Tips for Performing Effective Anti-Corruption Investigations in India,” you can access it here: Anti-Corruption Investigation Tips.
If you missed the first video in our series, “Ten Tips for Performing Effective Anti-Corruption Investigations in India,” you can access it here: Anti-Corruption Investigation Tips.
Author(s)
Related Insights
05 December 2024
Events
Relationships and Raising: How Female & Non-Binary Founders Can Leverage Networks for Fundraising
03 December 2024
Blogs
Supply Chain Integrity: Essential Insights for Multinational Automotive Companies
The U.S. government has increasingly emphasized the importance of supply chain integrity, particularly in relation to eliminating forced labor.
02 December 2024
Labor & Employment Law Perspectives
Department of Labor Clarifies Family and Medical Leave Act Leave Includes Treatment in Clinical Trials
As our readers are aware, eligible employees may take leave under the Family and Medical Leave Act for the treatment of a serious health condition.